Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Arm Holdings plc (ARM) vs GSK plc (GSK) Price & Performance

Arm Holdings plcTrade

Price performance (Past 24H)

Key statistics

Arm Holdings plc vs GSK plc — how do they compare? Arm Holdings plc trades at $278.89 (market cap $287.22B), while GSK plc trades at $50.28 (market cap $102.60B). The key difference: Arm Holdings plc is far larger — about 2.8× GSK plc's market cap, and GSK plc pays a 3.57% dividend while Arm Holdings plc pays none. Which is the better fit depends on your goals.

ARMGSK
Market Cap
$287.22B$102.60B
Sector
TechnologyHealth
52-Week High
$439.46$61.18
52-Week Low
$104.55$38.22
Enterprise Value
$283.79B$123.04B
Dividend Yield
3.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Arm Holdings plc

No Aura AI signal available yet.

GSK plc

GSK trades at $52.16, down 1.51% today, with a bullish technical signal supported by moving averages. The company reported strong Q2 2026 earnings of $1.36 per share, beating estimates, and announced a $2.52 billion cost-saving plan to accelerate drug development. Revenue growth remains steady, with 2025 revenue at $32.67 billion and net income of $5.72 billion, though profit margins have fluctuated in recent years.

Outlook is positive with continued earnings beats and strategic investments, but risks include competitive pressures and regulatory uncertainties. Analyst sentiment is mixed with 31% buy ratings, 55% hold, and 14% sell, reflecting cautious optimism amid execution risks and market volatility.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Arm Holdings plc

Arm Holdings designs the architecture for high-performance, energy-efficient processors used in nearly all smartphones and millions of other devices. Its intellectual property powers global computing from mobile to AI.

Read more on ARM

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Read more on GSK